Dublin, Jan. 16, 2025 (GLOBE NEWSWIRE) -- The "Subcutaneous Biologics Market, Industry Trends and Global Forecasts to 2035: Type of Biologic, Type of Therapy, Method of Administration, Fundamental ...
Please provide your email address to receive an email when new articles are posted on . Subcutaneous administration of a breast cancer therapy significantly decreased treatment time compared with IV ...
Administering Keytruda via subcutaneous injection instead of an intravenous drip.In September 2026, such a drug was approved.
The median total clinic time was not significantly shorter for patients who received subcutaneous trastuzumab/pertuzumab than for those who received the intravenous ...
A subcutaneous (SC) form of immune anticancer drug that can be administered in 1 to 2 minutes by injection into the skin has been newly approved in South Korea. MSD’s immune anticancer drug ‘Keytruda’ ...
Optimize ROI by targeting antibody-drug conjugates, subcutaneous delivery and Asia-Pacific expansion, backed by segment insights and competitive benchmarking.Dublin, Oct. 19, 2026 (GLOBE NEWSWIRE) -- ...
The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneously administered therapy for patients with epidermal growth ...
The Food and Drug Administration (FDA) has approved a form of the targeted drug isatuximab that can be given subcutaneously, or under the skin, for patients with multiple myeloma. Previously, the drug ...
Immunotherapy, exemplified by Opdivo, enhances cancer treatment by targeting malignant cells using the immune system, offering a more precise approach than traditional therapies. The FDA approved ...
Tecentriq Hybreza, a subcutaneous delivery of the drug, was approved for certain types of sarcoma, in addition to lung, skin and liver cancers. The Food and Drug Administration (FDA) approved ...
Increasing number of product approvals by regulatory authorities for the treatment of cancer is expected to drive growth of the subcutaneous drug delivery market. For instance, in February 2019, ...
“WELTRUZA offers the proven efficacy of olanzapine in an innovative long-acting subcutaneous injectable, helping to fill a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results